Simon Kouz

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters et al. · New England Journal of Medicine · 2019 · 2.8K citations · Full text

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer et al. · New England Journal of Medicine · 2017 · 768 citations · Full text

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure

Justin A. Ezekowitz, Eileen O’Meara, Michael McDonald et al. · Canadian Journal of Cardiology · 2017 · 678 citations

Heart Failure, Cardiovascular Disease, Health Policy +6

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Nadia Bouabdallaoui, Jean‐Claude Tardif, David D. Waters et al. · European Heart Journal · 2020 · 299 citations · Full text